target directory

amorphous calcium carbonate acc as a potential adjunct therapy for castrate resistant prostate cancer crpc with bone metastasis focusing on skeletal health and pain management clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.